Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for Intra-dialytic Hypotension
NCT01520207Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2012
- Primary completion
- Jul 2016
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intradialytic hypotension (IDH) comparing Placebo with Mannitol (2 arms). Primary endpoint: Efficacy of Mannitol Administration in Reducing the Frequency of Intra-dialytic Hypotension (Decline in Systolic Blood Pressure) During the First Three Hemodialysis Initiation Sessions. Started May 2012; status: completed.
02
Drugs
Bronchitol
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on NCT01520207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520207.